To study the effect of shirish twaka ghrita application in treatment of atopic dermatitis

Comparative clinical study of efficacy of shrish twaka ghrita application with clobetasole ointment (clobetasole propionate) in management of charmadala in children with special reference to atopic dermatitis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042504

Enrollment

Registered

2022-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of charmadala.

Exclusion criteria

Exclusion criteria: 1]patient having any other type of kshudrakushtha or mahakushtha other than charmadala. 2]patients with complications of wheeping of affected part or infected lesions. 3]patient having other associated illness like diarhoea, acute respiratory infections and acute febrile or other disorders are excluded from the study. 4]patient with sever form of other systemic and metabolic disorders. 5]HIV ad HbSAg positive patients. 6]allergic reactions to systemic/topical study drugs

Design outcomes

Primary

Measure	Time frame
1. To assess the clinical efficacy of shrish twaka ghrita application in management of charmadala in kaumar awastha. The changes observed after treatment will be assessed on the basis of reduction in following signs and symptoms- kandu(itching), discharge(strava), vaivarnyata(disccolouration), daha(burning sensation), rukshata(dryness). Timepoint: 0-60 days	—

Secondary

Measure	Time frame
1. To assess the clinical efficacy of Clobetasole Proprionate ointment in management of Charmadala in kaumar-awastha 2. To study the pathophysiology of Charmadala in kaumar-awastha The changes observed after treatment will assessed on the basis of reduction in following signs and symptoms- 1]Kandu(itching) 2]Discharge(strava) 3]Vaivarnyata(discolouration) 4]Daha(burning sensation) 5]Rukshata(dryness) The primary study outcomes arise from and align directly with the primary study aim or objective. Likewise, any secondary study outcomes arise from and directly align with any secondary study aim or objective Timepoint: 0-60 days	—

Measure

Time frame

1. To assess the clinical efficacy of Clobetasole Proprionate ointment in management of Charmadala in kaumar-awastha 2. To study the pathophysiology of Charmadala in kaumar-awastha The changes observed after treatment will assessed on the basis of reduction in following signs and symptoms- 1]Kandu(itching) 2]Discharge(strava) 3]Vaivarnyata(discolouration) 4]Daha(burning sensation) 5]Rukshata(dryness) The primary study outcomes arise from and align directly with the primary study aim or objective. Likewise, any secondary study outcomes arise from and directly align with any secondary study aim or objective Timepoint: 0-60 days

—

Countries

India

Contacts

Public ContactDr Deepesh Naik

D.Y Patil Deemed to be University

dhurikalpana34@gmail.com9321835616

Outcome results